Chai Discovery
-4%
est. 2Y upside i
Chai has built an AI model that its founders claim can transform the process of designing molecules that bind to proteins and influence their function. The company aims to enable the creation of de novo antibodies and, ultimately, drugs.
Rank
#2393
Sector
AI Drug Discovery
Est. Liquidity
~2Y
Data Quality
Data: LowChai Discovery offers significant potential given its cutting-edge AI platform and pharma partners, but the $3.8B valuation is based on future expectations without disclosed revenue.
Last updated: July 19, 2026
IPO within 2 years drives valuation to $6.8B (1.8x current) based on strong AI platform and pharma demand; after 5% dilution, net upside 71%.
Valuation remains flat at $3.8B as revenue growth is steady but not transformative; 5% dilution results in slight negative return.
Valuation compresses to $1.9B (50% decline) due to competitive pressure or missed milestones; after 5% dilution, net downside -52.5%.
Preference Stack Risk
moderateFunding Intensity
17%Total funding of $630M on $3.8B valuation gives 16.6% preference overhang.
Dilution Risk
lowRecent $400M Series C provides ample runway, reducing near-term dilution risk.
Secondary Liquidity
noneNo secondary market data available.
Commercial — 3 roles
- Forward-Deployed Scientist · San Francisco office
- Partnerships, Alliance Management · San Francisco office
- Partnerships, Business Development · San Francisco office
Engineering — 2 roles
- Software Engineer, Infrastructure · San Francisco office
- Software Engineer, Product · San Francisco office
Other — 2 roles
- Internship · San Francisco office
- Outliers & Polymaths · San Francisco office
Research — 2 roles
- Research Engineer · San Francisco office
- Research Scientist · San Francisco office
Science — 2 roles
- Antibody Engineering · San Francisco office
- Data Generation at Scale · San Francisco office
Product — 1 role
- Product Designer · San Francisco office
Last updated: March 10, 2026
Questions to Ask at the Interview
Strategic questions based on Chai Discovery's data — designed to show you've done your homework.
- 1
“What is Chai's current revenue run rate and growth trajectory?”
- 2
“How does Chai's AI differentiate from Isomorphic Labs and Recursion?”
- 3
“What is the expected timeline to IPO or next liquidity event?”
Community
Valuation Sentiment
Our model estimates -4% upside. What do you think?
Anonymous. Do not share material non-public information.
Community Discussion
Comments are reviewed before they appear publicly.
Loading comments...
Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.